ArticleJournal of robotic surgery2026
Beyond total operative time: phase-specific robotic efficiency and postoperative morbidity following colorectal resection - a multisurgeon cohort study.
Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Robotic colorectal surgery is associated with longer operative times than conventional laparoscopic approaches, yet total operative duration is a composite measure comprising fundamentally different procedural components. It remains unknown as to whether postoperative morbidity is attributable to overall operative length or to specific phases of the robotic procedure. A retrospective single-centre cohort study at York and Scarborough NHS Foundation Trust, UK, included consecutive robotic colorectal resections performed by eight consultant surgeons (Surgeons A-H). Two prespecified cohorts were analysed: Cohort A (primary, N = 490) with complete knife-to-skin and case-completion timestamps; Cohort B (nested, N = 138) with complete intraoperative phase timestamps across six predefined phases. The primary outcome was a composite comprising prespecified postoperative complications, readmission and return to theatre within 30 days, plus all-cause mortality within 90 days. Multivariable binary logistic regression was used to examine associations with total operative duration; restricted cubic splines were used as an exploratory assessment of functional form. In Cohort A (N = 490), the primary composite endpoint occurred in 113 patients (23.1%). Median total operative time was 354 min (IQR 270-442). On multivariable analysis, each additional 30 min of operative duration was independently associated with increased odds of the composite endpoint (adjusted OR 1.08, 95% CI 1.01-1.17, p = 0.036). Greater within-programme cumulative case experience was associated with lower odds of morbidity (OR 0.82 per 10 additional cases, 95% CI 0.73-0.92, p < 0.001). In Cohort B (N = 138; 41 events), no individual operative phase reached statistical significance in the originally fitted adjusted phase models; these phase-level analyses are exploratory and should not be interpreted as evidence that any individual phase is unrelated to morbidity. A longer total operative duration was independently associated with our composite morbidity endpoints after adjustment for age, within-programme case experience, operating surgeon and procedure type. Within the smaller nested phase-timing cohort, no individual phase revealed a statistically significant independent association. These phase-level findings are exploratory and do not establish whether console or non-console components mediate the association observed with total operative duration.
Indexed as
Identifiers
42828597What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.